NEMO-binding domain peptide inhibits constitutive NF-κB activity and reduces tumor burden in a canine model of relapsed, refractory diffuse large B-cell lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research Jul, 2011 | Pubmed ID: 21610150